Ni Jiang Selected Research

Ni Jiang Research Topics

Disease

21	Neoplasms (Cancer) 03/2024 - 01/2015
5	Adenocarcinoma of Lung 04/2023 - 09/2019
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 09/2019
3	Hypoxia (Hypoxemia) 01/2022 - 01/2020
2	Pancreatic Neoplasms (Pancreatic Cancer) 05/2023 - 09/2017
2	Neoplasm Metastasis (Metastasis) 04/2023 - 01/2022
2	Schistosomiasis (Bilharziasis) 03/2022 - 10/2020
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 01/2022
2	Hematologic Neoplasms (Hematological Malignancy) 01/2014 - 12/2006
1	Tissue Adhesions 03/2024
1	Bites and Stings (Sting) 03/2024
1	Lymphatic Metastasis 04/2023
1	Esophageal Achalasia (Megaesophagus) 03/2023
1	Jaundice (Icterus) 02/2023
1	Hemolytic Anemia 02/2023
1	Ovarian Neoplasms (Ovarian Cancer) 01/2023
1	Anemia 01/2023
1	Anorexia 01/2023
1	Fatigue 01/2023
1	Leukopenia 01/2023
1	Nausea 01/2023
1	Vomiting 01/2023
1	Postpartum Depression (Post-Natal Depression) 01/2023
1	Ischemic Stroke 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Wounds and Injuries (Trauma) 01/2022
1	Non-Muscle Invasive Bladder Neoplasms 01/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	COVID-19 10/2020
1	Infections 10/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 03/2020
1	Leukemia 03/2020
1	Hyperthermia 11/2019
1	Endometrial Neoplasms (Endometrial Cancer) 11/2019
1	Thrombosis (Thrombus) 05/2019

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 05/2023 - 07/2017
4	Biomarkers (Surrogate Marker)IBA 05/2023 - 01/2022
2	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2024 - 10/2020
2	CytokinesIBA 01/2023 - 11/2019
2	Long Noncoding RNAIBA 04/2022 - 01/2022
2	Niclosamide FDA Link 03/2022 - 10/2020
2	Immune Checkpoint InhibitorsIBA 01/2022 - 11/2019
2	Peptide Hydrolases (Proteases)FDA Link 03/2020 - 01/2020
1	ProdrugsIBA 03/2024
1	gambogic acidIBA 03/2024
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 03/2024
1	Hyaluronic Acid (Hyaluronan)IBA 03/2024
1	InterferonsIBA 03/2024
1	UbiquitinIBA 11/2023
1	Matrix Metalloproteinases (MMPs)IBA 05/2023
1	Bleomycin (Blenoxane)FDA LinkGeneric 05/2023
1	1-methyl-1H-indole-2-carboxylic acid (4- (1- (4- (4- acetylpiperazin- 1- yl)cyclohexyl)- 4- amino- 1H- pyrazolo(3,4- d)pyrimidin- 3- yl)- 2- methoxyphenyl)amideIBA 05/2023
1	Microfilament Proteins (Actin Binding Proteins)IBA 05/2023
1	dactolisibIBA 05/2023
1	cytochrome P-450 CYP4B1 (CYP4B1)IBA 04/2023
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 03/2023
1	Cyclin D1IBA 03/2023
1	Hemoglobins (Hemoglobin)IBA 02/2023
1	Gefitinib (Iressa)FDA Link 01/2023
1	Tuberculin (PPD)IBA 01/2023
1	Aurora Kinase AIBA 01/2023
1	Cyclin B1IBA 12/2022
1	IntegrinsIBA 04/2022
1	Apolipoprotein C-I (Apolipoprotein C1)IBA 01/2022
1	Protein CoronaIBA 01/2022
1	Transaminases (Aminotransferases)IBA 01/2022
1	Nerve Growth Factor (NGF)IBA 01/2022
1	tislelizumabIBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2022
1	Transforming Growth Factors (Transforming Growth Factor)IBA 03/2021
1	sinomenineIBA 01/2021
1	AntioxidantsIBA 10/2020
1	VaccinesIBA 10/2020
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 10/2020
1	CatalaseIBA 10/2020
1	EnzymesIBA 10/2020
1	Cysteine (L-Cysteine)FDA Link 03/2020
1	AcidsIBA 03/2020
1	Molecular Probes (Molecular Probe)IBA 01/2020
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2019
1	pembrolizumabIBA 11/2019
1	Interleukin-4 (Interleukin 4)IBA 11/2019
1	Interleukin-2 (IL2)IBA 11/2019
1	Circulating Tumor DNAIBA 09/2019
1	ErbB Receptors (EGF Receptor)IBA 09/2019
1	Tyrosine Kinase InhibitorsIBA 09/2019
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 05/2019
1	AnticoagulantsIBA 05/2019

Therapy/Procedure

9	Immunotherapy 03/2024 - 09/2017
6	Therapeutics 01/2023 - 01/2017
5	Drug Therapy (Chemotherapy) 01/2023 - 01/2015
1	Myotomy 03/2023
1	Radiotherapy 01/2023
1	Transplantation 01/2022
1	Cell- and Tissue-Based Therapy (Cell Therapy) 11/2019
1	Blood Component Removal (Apheresis) 05/2019
1	Catheters 05/2019